Terje R. Pedersen
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Health Systems, Economic Evaluations, Quality of Life, Diabetes, Cardiovascular Risks, and Lipoproteins, Cardiac Valve Diseases and Treatments, Pharmaceutical Economics and Policy
Most-Cited Works
- → 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk(2019)8,581 cited
- → Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease(2017)5,779 cited
- → 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk(2019)4,829 cited
- → 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias(2016)3,169 cited
- → Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)(2004)3,118 cited
- → Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials(2010)2,426 cited
- → Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)(1997)1,638 cited
- → Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis(2008)1,607 cited
- → High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction<SUBTITLE>The IDEAL Study: A Randomized Controlled Trial</SUBTITLE>(2005)1,549 cited